This April, Roche announced it will invest $50 billion into the U.S. in the next five years. As part of this investment, Roche will increase its existing footprint of more than 25,000 employees in 24 sites across eight states, including Massachusetts. The investment will include a new R&D center in Massachusetts, which according to the company, will conduct cutting-edge AI research and serve as a hub for Roche’s new cardiovascular, renal and metabolism research and development efforts.
Massachusetts is the home of revolutions and age defining breakthroughs. It’s where state-of-the-art facilities and innovation hubs from Cambridge to Worcester and throughout our commonwealth lead the charge in discovering our future. It’s where the work and mission of companies such as Roche and many others have the greatest opportunity to change the world. Learn more about why Massachusetts remains the best place to discover, develop, and scale.
Read more via Roche.
